Archive

Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results

NASDAQ, TSX: NVCN Recent Highlights The U.S. Food and Drug Administration (the "FDA") granted Breakthrough Device designation to the Neovasc Reducer™ (the "Reducer") for the treatment of refractory angina Reducer implanted in 100th patient in Germany 5-Year anniversary of Tiara™ (the "Tiara") patient celebrated as the...

Read More

Neovasc Wins German Court Appeal; Announces German Court’s Decision to Dismiss CardiAQ’s Claim to Co-inventorship of a European Patent for Tiara™

NASDAQ, TSX: NVCN VANCOUVER, March 21, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory...

Read More

Neovasc Announces Closing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 15, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has closed its previously announced underwritten public offering (the "Offering") of 11,111,111 common shares of the Company (the "Common Shares") at...

Read More

Neovasc Completes Successful Quality System Surveillance Audit

NASDAQ, TSX: NVCN VANCOUVER, March 14, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory...

Read More

Neovasc Announces Pricing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 13, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten public offering (the "Offering") of 11,111,111 common shares of the Company (the "Common Shares") at a...

Read More

Neovasc Announces Proposed Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 12, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has commenced a proposed underwritten public offering (the "Offering") of common shares of the Company (the "Common Shares"). H.C. Wainwright...

Read More